A comparative study of the membrane-protector efficacy of anaprilin and korinfar in hypertension patients

Beta-blocker anapriline and calcium antagonist corinfar are highly effective hypotensive agents. Drop in diastolic arterial pressure with anapriline therapy amounted to 15.9 and 15.6%, with corinfar therapy-to 15.0 and 15.6% in hypertensive disease stage I and II respectively. Hypotensive action of...

Full description

Saved in:
Bibliographic Details
Published inLikars'ka sprava no. 10-12; pp. 69 - 71
Main Authors Gapon, L I, Kremneva, L V, Abaturova, O V
Format Journal Article
LanguageRussian
Published Ukraine 01.10.1996
Subjects
Adolescent
Adrenergic beta-Antagonists - pharmacology
Adrenergic beta-Antagonists - therapeutic use
Adult
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
Calcium Channel Blockers - pharmacology
Calcium Channel Blockers - therapeutic use
Drug Evaluation
Electrolytes - blood
Erythrocyte Membrane - drug effects
Erythrocyte Membrane - metabolism
Humans
Hypertension - blood
Hypertension - drug therapy
Membrane Lipids - blood
Middle Aged
Nifedipine - pharmacology
Nifedipine - therapeutic use
Phospholipids - blood
Propranolol - pharmacology
Propranolol - therapeutic use
Online AccessGet full text

Cover

More Information
Summary:Beta-blocker anapriline and calcium antagonist corinfar are highly effective hypotensive agents. Drop in diastolic arterial pressure with anapriline therapy amounted to 15.9 and 15.6%, with corinfar therapy-to 15.0 and 15.6% in hypertensive disease stage I and II respectively. Hypotensive action of corinfar might result from correction of impaired cation-transport function of cellular membranes, electrolyte homeostasis of cells, phospholipid composition of membranes. No dynamics has been revealed of the membrane tests under study during administration of anapriline therapy treatments.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1019-5297